A man in southern California, dubbed the 'City of Hope patient', appears to be the latest person cured of HIV after receiving a stem cell transplant from a donor with a rare mutation, bringing the ...

Over half of funding for anti-gender actors in Europe appears to come from within Europe itself, with significant amounts of money also flowing from the US and the Russian Federation, according to ...

It’s rare in any branch of medicine that a trial of a new drug can report 100% efficacy, and a first in HIV science. But that’s what happened on Friday, when Gilead Sciences announced that no HIV ...

The British HIV Association (BHIVA) conference in Gateshead this week heard the results of the first year’s rollout of opt-out testing for HIV and hepatitis B and C for all patients attending ...

In 2019, South Africa adopted dolutegravir / lamivudine / tenofovir (TLD) as its preferred first-line regimen, replacing a regimen known as TEE or tenofovir / emtricitabine / efavirenz for most adults ...

Gay Muslim men living with HIV in Dakar face persecution such as violence and incarceration due to their sexuality. Many are socially isolated, often because of religious or political factors, despite ...

Advocates from around the world came together at the U=U Global Summit at the 24th International AIDS Conference (AIDS 2022) in Montreal last month to share successes and challenges that continue to ...

The British HIV Association (BHIVA) has recommended that everyone living with HIV aged 40 and over should take a statin to reduce their risk of heart disease, even if they do not have raised ...

An Israeli biotech company has issued a misleading press release which has encouraged some media outlets to falsely suggest that a new drug, Gammora, may be able to cure HIV. Zion Medical report that ...

Health managers leveraged government funding for primary care, maternal and child health, sanitation and environmental health, and immunisation services to ensure the continuity of HIV/AIDS services.

Two broadly neutralising antibodies, teropavimab and zinlirvimab, might be good partners for lenacapavir (Sunlenca) in a long-acting HIV treatment regimen, according to study results presented ...

A detailed analysis of results from the HPTN 083 PrEP study, which compared the efficacy of a two-monthly injection of the drug cabotegravir against daily oral tenofovir disoproxil fumarate and ...